In a notable advance in regenerative medicine, researchers at Texas A&M University have reported that a simple nasal spray can reduce brain inflammation, restore cellular energy function, and improve memory in aging mice. The findings, published in 2026, have generated excitement about potential future treatments for age-related cognitive decline.
Promising Preclinical Results
The study, led by Dr. Ashok Shetty and colleagues including Madhu Leelavathi Narayana and Maheedhar Kodali, used extracellular vesicles (EVs) derived from human neural stem cells. These microscopic particles carry beneficial microRNAs that help regulate gene activity in the brain.
The nasal spray was administered in just two doses to late middle-aged mice, roughly equivalent to humans in their early 60s. Because the spray delivers the EVs directly through nasal pathways, it effectively bypasses the blood-brain barrier, allowing the therapeutic particles to reach the hippocampus—the brain region critical for memory and learning.
Within weeks, and with effects lasting for months, the treated mice showed several key improvements:
- Significant reduction in chronic neuroinflammation, including lowered activity of inflammatory pathways such as the NLRP3 inflammasome and cGAS-STING.
- Restoration of mitochondrial function, enhancing the energy production capacity of brain cells.
- Better performance in memory and cognitive tests.
Importantly, the benefits were observed consistently in both male and female mice.
Why This Research Matters
As people age, low-grade chronic inflammation in the brain—often called “neuroinflammaging”—contributes to cognitive fog, memory problems, and increased risk of neurodegenerative conditions like Alzheimer’s disease. By targeting inflammation and cellular health rather than just masking symptoms, this approach suggests that certain aspects of brain aging may be more reversible than previously believed.
The research was supported by the National Institute on Aging (part of the NIH), and Texas A&M University has already filed a patent on the technology. The full study appeared in the Journal of Extracellular Vesicles (DOI: 10.1002/jev2.70232).
Important Limitations
While the results are encouraging, this remains early-stage, preclinical research. All experiments were conducted in mice, and many treatments that succeed in animal models do not translate successfully to humans. Human clinical trials will be necessary to determine safety, optimal dosing, effectiveness, and any potential long-term side effects.
Experts emphasize that the nasal spray is not yet available for human use and is not a proven cure for aging or advanced neurological diseases. Media headlines may sometimes overstate the immediacy of such findings.
Looking Ahead
This work adds to the growing field of using stem cell-derived extracellular vesicles for brain health. Researchers and institutions will likely continue monitoring progress through clinical trial registries and future publications.
In the meantime, established lifestyle approaches—regular physical exercise, quality sleep, a healthy diet, and mental stimulation—remain the most reliable ways to support brain health as we age.
This Texas A&M study offers a hopeful glimpse into future therapies, but patience and further rigorous testing will be essential before any such nasal spray reaches patients.
About The Author
